Not applicableEnded earlyNCT01324297What this trial is testingThe Topical Niacin Skin Flush Test in First Episode PsychosisWho this might be right forPsychotic DisordersSchizophrenia Nova Scotia Health Authority 107
Early research (Phase 1)Study completedNCT00255918What this trial is testingInvestigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia PatientsWho this might be right forSchizophreniaPsychotic Disorders University of Colorado, Denver 12
Not applicableNot Yet RecruitingNCT07184710What this trial is testingThis Hospital-based Observational Study Employed a Study Will be Conducted in Sohag University Hospital Clinics Aiming to Ensure Cases Presented With Psychosis in Two Phases to Differentiate Into Two Groups a Case of Schizophrenia or a Case of Methamphetamine Induced Psychosis.Who this might be right forComparing Clinical Profile and Prognosis of Schizophrenia Versus Methamphetamine Induced PsychosisSCHIZOPHRENIAMethamphetamine Induced Psychosis Sohag University 200
Not applicableStudy completedNCT01959659What this trial is testingA Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of IllnessWho this might be right forSchizophrenia Hoffmann-La Roche 1,431
Large-scale testing (Phase 3)UnknownNCT04093518What this trial is testingEstradiol as add-on to AntipsychoticsWho this might be right forSchizophreniaSchizoaffective DisorderSchizophreniform Disorders Tangent Data 100
Testing effectiveness (Phase 2)Study completedNCT00884897What this trial is testingOxytocin and Social Cognition in SchizophreniaWho this might be right forSocial CognitionSocial AnxietyEmotional Intelligence University of Maryland, Baltimore 28
Not applicableLooking for participantsNCT05704582What this trial is testingRCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic DisordersWho this might be right forPsychotic DisordersCannabis Use DisorderMental Health Disorder Ciusss de L'Est de l'Île de Montréal 150
Post-approval studies (Phase 4)Study completedNCT00203788What this trial is testingImproving Work Outcome in People With Recent-onset SchizophreniaWho this might be right forSchizophrenia University of California, Los Angeles 87
Not applicableActive Not RecruitingNCT00001246What this trial is testingBrain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy VolunteersWho this might be right forAttention Deficit Hyperactivity DisorderSchizophreniaAttention Deficit Disorder With Hyperactivity National Institute of Mental Health (NIMH) 4,274
Post-approval studies (Phase 4)Ended earlyNCT00256997What this trial is testingRisperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their MedicationWho this might be right forSchizophrenia Janssen-Ortho Inc., Canada 167
Post-approval studies (Phase 4)Study completedNCT00485823What this trial is testingAssessment of a Weight Management Program for Weight Gain in Patients With SchizophreniaWho this might be right forSchizophrenic Disorders Eli Lilly and Company 48
Not applicableStudy completedNCT02748486What this trial is testingEfficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize...Who this might be right forSchizophreniaPsychotic Disorders University of Warsaw 38
Testing effectiveness (Phase 2)Study completedNCT02008773What this trial is testingTrial of Adjunctive Valacyclovir to Improve Cognition in Early Phase SchizophreniaWho this might be right forSchizophrenia Indiana University 170
Testing effectiveness (Phase 2)Study completedNCT00257023What this trial is testingAn Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With SchizophreniaWho this might be right forSchizophrenia Janssen Pharmaceutical K.K. 52
Early research (Phase 1)Study completedNCT00541996What this trial is testingStudy Comparing Bioavailability of Oral Formulations of VabicaserinWho this might be right forSchizophrenia Wyeth is now a wholly owned subsidiary of Pfizer
Post-approval studies (Phase 4)Study completedNCT01947803What this trial is testingA Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With SchizophreniaWho this might be right forSchizophrenia Xian-Janssen Pharmaceutical Ltd. 353
Early research (Phase 1)Study completedNCT00628420What this trial is testingSafety Study of ACP-104: To Demonstrate the Safety, Tolerability, and PharmacokineticsWho this might be right forSchizophrenia University of Texas Southwestern Medical Center 45
Large-scale testing (Phase 3)Study completedNCT04659174What this trial is testingAn Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)Who this might be right forSchizophrenia Karuna Therapeutics, Inc., a Bristol Myers Squibb company 152
Testing effectiveness (Phase 2)Study completedNCT01623713What this trial is testingEfficacy and Safety Study of Iloperidone Virus Risperidone to Treat SchizophreniaWho this might be right forSchizophreniaIloperidoneEfficacy Jiangsu Hansoh Pharmaceutical Co., Ltd. 260
Not applicableUnknownNCT01510015What this trial is testingEvaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in IsraelWho this might be right forCannabis DependencePsychostimulant Dependence Tel-Aviv Sourasky Medical Center 100